{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:39:12Z","timestamp":1793194752600,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2021-126781OB-I00"],"award-info":[{"award-number":["PID2021-126781OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FJC2020-042865-I"],"award-info":[{"award-number":["FJC2020-042865-I"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP17CIII\/00007"],"award-info":[{"award-number":["CP17CIII\/00007"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00657"],"award-info":[{"award-number":["PI17\/00657"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00903"],"award-info":[{"award-number":["PI17\/00903"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17CIII\/00003"],"award-info":[{"award-number":["PI17CIII\/00003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18CIII\/00020"],"award-info":[{"award-number":["PI18CIII\/00020"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18CIII\/00028"],"award-info":[{"award-number":["PI18CIII\/00028"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00474"],"award-info":[{"award-number":["PI20\/00474"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00507"],"award-info":[{"award-number":["PI20\/00507"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20CIII\/00004"],"award-info":[{"award-number":["PI20CIII\/00004"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21CIII\/00033"],"award-info":[{"award-number":["PI21CIII\/00033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.biopha.2023.114913","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T23:28:41Z","timestamp":1684538921000},"page":"114913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV\/HCV-coinfected patients"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6262-9344","authenticated-orcid":false,"given":"Rub\u00e9n","family":"Mart\u00edn-Escolano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Virseda-Berdices","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8372-2604","authenticated-orcid":false,"given":"Oscar","family":"Brochado-Kith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-2213","authenticated-orcid":false,"given":"Amanda","family":"Fern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Honta\u00f1on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8783-0450","authenticated-orcid":false,"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Jim\u00e9nez-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.biopha.2023.114913_bib1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":": Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10207","key":"10.1016\/j.biopha.2023.114913_bib2","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2023.114913_bib3","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/hep.25791","article-title":"Hepatic steatosis and steatohepatitis in human immunodeficiency virus\/hepatitis C virus-coinfected patients","volume":"56","author":"Macias","year":"2012","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.biopha.2023.114913_bib4","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jhep.2005.11.008","article-title":"Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection","volume":"44","author":"Vallet-Pichard","year":"2006","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib5","first-page":"24","article-title":"Steatosis and hepatitis C","volume":"4","author":"Modaresi Esfeh","year":"2016","journal-title":"Gastroenterol. Rep."},{"issue":"11\u201312","key":"10.1016\/j.biopha.2023.114913_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/apt.17233","article-title":"Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis C virus infection-a population-based study","volume":"56","author":"Attia","year":"2022","journal-title":"Aliment Pharm. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/apt.16706","article-title":"Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharm. Ther."},{"issue":"6","key":"10.1016\/j.biopha.2023.114913_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/17474124.2019.1599284","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in HIV infection: a metabolic approach of an infectious disease","volume":"13","author":"Coronel-Castillo","year":"2019","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114913_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jdi.13966","article-title":"Diagnostic ability using fatty liver and metabolic markers for metabolic-associated fatty liver disease stratified by metabolic\/glycemic abnormalities","volume":"14","author":"Okada","year":"2023","journal-title":"J. Diabetes Invest."},{"issue":"7","key":"10.1016\/j.biopha.2023.114913_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.biopha.2023.114913_bib11","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/hiv.13060","article-title":"Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and\/or advanced liver fibrosis in people living with HIV","volume":"22","author":"Yanavich","year":"2021","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.biopha.2023.114913_bib12","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1093\/cid\/ciac708","article-title":"Liver Inflammation is common and linked to metabolic derangements in persons with treated human immunodeficiency Virus (HIV)","volume":"76","author":"Chew","year":"2023","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2023.114913_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.29071","article-title":"Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus\/hepatitis C virus coinfection","volume":"66","author":"Berenguer","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2023.114913_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","article-title":"Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"50","author":"Berenguer","year":"2009","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2023.114913_bib15","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1093\/cid\/ciaa502","article-title":"Persistence of clinically significant portal hypertension after eradication of hepatitis C virus in patients with advanced cirrhosis","volume":"71","author":"Diez","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jinf.2022.11.004","article-title":"Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus","volume":"86","author":"Santos","year":"2023","journal-title":"J. Infect."},{"issue":"8","key":"10.1016\/j.biopha.2023.114913_bib17","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2023.114913_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008181","article-title":"Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals","volume":"15","author":"Perez","year":"2019","journal-title":"PLoS Genet"},{"issue":"10","key":"10.1016\/j.biopha.2023.114913_bib19","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/apt.16346","article-title":"MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective","volume":"53","author":"Fouad","year":"2021","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.biopha.2023.114913_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.coviro.2021.08.011","article-title":"T cell responses during HBV and HCV infections: similar but not quite the same?","volume":"51","author":"Shoukry","year":"2021","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114913_bib21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.114913_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/v12080799","article-title":"Reversal of T cell exhaustion in chronic HCV infection","volume":"12","author":"Osuch","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.114913_bib23","article-title":"Increase in serum soluble tim-3 level is related to the progression of diseases after hepatitis virus infection","volume":"9","author":"Chen","year":"2022","journal-title":"Front Med."},{"issue":"6","key":"10.1016\/j.biopha.2023.114913_bib24","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2023.114913_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/v14030581","article-title":"Expression profile and biological role of immune checkpoints in disease progression of HIV\/SIV infection","volume":"14","author":"Sun","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.biopha.2023.114913_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/ijms23052707","article-title":"PD-1\/PD-L1 immuno-mediated therapy in NAFLD: advantages and obstacles in the treatment of advanced disease","volume":"23","author":"Lombardi","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.114913_bib27","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy","volume":"47","author":"Tada","year":"2018","journal-title":"Aliment Pharm. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2023.114913_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000001106","article-title":"Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"30","author":"Kobayashi","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2023.114913_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jceh.2018.06.009","article-title":"Therapy with oral directly acting agents in hepatitis C infection is associated with reduction in fibrosis and increase in hepatic steatosis on transient elastography","volume":"9","author":"Rout","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2023.114913_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.dld.2020.11.001","article-title":"Metabolic comorbidities and male sex influence steatosis in chronic hepatitis C after viral eradication by direct-acting antiviral therapy (DAAs): Evaluation by the controlled attenuation parameter (CAP)","volume":"53","author":"Cespiati","year":"2021","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.biopha.2023.114913_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/biomedicines11020271","article-title":"Hepatitis C virus-lipid interplay: pathogenesis and clinical impact","volume":"11","author":"Elgretli","year":"2023","journal-title":"Biomedicines"},{"issue":"5","key":"10.1016\/j.biopha.2023.114913_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jhep.2008.01.015","article-title":"Hepatic steatosis in HIV\/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study","volume":"48","author":"Rodriguez-Torres","year":"2008","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.114913_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jhep.2003.11.004","article-title":"The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients","volume":"40","author":"Patton","year":"2004","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2023.114913_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269641","article-title":"Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants","volume":"17","author":"Chuaypen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114913_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/diagnostics12030702","article-title":"Changes in liver steatosis using controlled attenuation parameter among patients with chronic hepatitis C infection treated with direct-acting antivirals therapy who achieved sustained virological response","volume":"12","author":"Trifan","year":"2022","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.biopha.2023.114913_bib36","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jvh.13167","article-title":"Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response","volume":"26","author":"Peleg","year":"2019","journal-title":"J. Viral Hepat."},{"issue":"7","key":"10.1016\/j.biopha.2023.114913_bib37","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s10620-020-06457-2","article-title":"Nonalcoholic fatty liver Disease risk factors affect liver-related outcomes after direct-acting antiviral treatment for hepatitis C","volume":"66","author":"Benhammou","year":"2021","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.biopha.2023.114913_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/biomedicines10112809","article-title":"Immune Checkpoint molecules and glucose metabolism in HIV-induced T cell exhaustion","volume":"10","author":"Chan","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.biopha.2023.114913_bib39","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat. Med"},{"issue":"11","key":"10.1016\/j.biopha.2023.114913_bib40","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/ni1515","article-title":"Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction","volume":"8","author":"Kaufmann","year":"2007","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005349","article-title":"TIGIT marks exhausted t cells, correlates with disease progression, and serves as a target for immune restoration in HIV and SIV infection","volume":"12","author":"Chew","year":"2016","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3350\/cmh.2022.0032","article-title":"Hepatocytes infected with hepatitis C virus change immunological features in the liver microenvironment","volume":"29","author":"Park","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.biopha.2023.114913_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3389\/fcimb.2019.00207","article-title":"The PD-1\/PD-L1 axis and virus infections: a delicate balance","volume":"9","author":"Schonrich","year":"2019","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.biopha.2023.114913_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/healthcare10091616","article-title":"The related metabolic diseases and treatments of obesity","volume":"10","author":"Yang","year":"2022","journal-title":"Healthcare"},{"key":"10.1016\/j.biopha.2023.114913_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827921","article-title":"Biological characteristics and clinical significance of soluble PD-1\/PD-L1 and Exosomal PD-L1 in Cancer","volume":"13","author":"Niu","year":"2022","journal-title":"Front Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2023.114913_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7150\/ijms.18784","article-title":"Increase of soluble programmed cell death ligand 1 in patients with chronic hepatitis C","volume":"14","author":"Yamagiwa","year":"2017","journal-title":"Int J. Med Sci."},{"key":"10.1016\/j.biopha.2023.114913_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.654960","article-title":"Roles of BTLA in immunity and immune disorders","volume":"12","author":"Ning","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.114913_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellimm.2016.12.002","article-title":"CD8+ T cells of chronic HCV-infected patients express multiple negative immune checkpoints following stimulation with HCV peptides","volume":"313","author":"Barathan","year":"2017","journal-title":"Cell Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib49","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1038\/s41598-019-47024-8","article-title":"HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules","volume":"9","author":"Ackermann","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169176","article-title":"Soluble B and T lymphocyte attenuator correlates to disease severity in sepsis and high levels are associated with an increased risk of mortality","volume":"12","author":"Lange","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.114913_bib51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coi.2017.07.016","article-title":"Check point inhibitors as therapies for infectious diseases","volume":"48","author":"Cox","year":"2017","journal-title":"Curr. Opin. Immunol."},{"issue":"ltab025","key":"10.1016\/j.biopha.2023.114913_bib52","first-page":"1","article-title":"Seven mysteries of LAG-3: a multi-faceted immune receptor of increasing complexity","volume":"2","author":"Burnell","year":"2022","journal-title":"Immunother. Adv."},{"key":"10.1016\/j.biopha.2023.114913_bib53","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fphys.2020.00873","article-title":"Prominent receptors of liver sinusoidal endothelial cells in liver homeostasis and disease","volume":"11","author":"Pandey","year":"2020","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2023.114913_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.30956","article-title":"Unraveling the pathophysiologic role of galectin-3 in chronically injured liver","author":"Ezhilarasan","year":"2023","journal-title":"J. Cell Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.114913_bib55","doi-asserted-by":"crossref","first-page":"292","DOI":"10.7150\/ijbs.66834","article-title":"Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential","volume":"18","author":"Liu","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.114913_bib56","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/hep.27233","article-title":"Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation","volume":"60","author":"Chatzigeorgiou","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2023.114913_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.651634","article-title":"Soluble B7-CD28 family inhibitory immune checkpoint proteins and anti-cancer immunotherapy","volume":"12","author":"Khan","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2023.114913_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.918837","article-title":"The long and winding road: From mouse linkage studies to a novel human therapeutic pathway in type 1 diabetes","volume":"13","author":"Rojas","year":"2022","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2023.114913_bib59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/eji.202149488","article-title":"Soluble CD137 is a novel serum marker of liver cirrhosis in patients with hepatitis C and alcohol-associated disease etiology","volume":"52","author":"Weigand","year":"2022","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2023.114913_bib60","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/ijo.2013.222","article-title":"Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters","volume":"38","author":"Tu","year":"2014","journal-title":"Int J. Obes."},{"key":"10.1016\/j.biopha.2023.114913_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.588682","article-title":"The role of GITR\/GITRL interaction in autoimmune diseases","volume":"11","author":"Tian","year":"2020","journal-title":"Front Immunol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223007035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:09:25Z","timestamp":1793192965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223007035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":61,"alternative-id":["S0753332223007035"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114913","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV\/HCV-coinfected patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.114913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114913"}}